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Abstract: This paper describes a methodology that extracts key morphological features from
histological breast cancer images in order to automatically assess Tumour Cellularity (TC) in
Neo-Adjuvant treatment (NAT) patients. The response to NAT gives information on therapy efficacy
and it is measured by the residual cancer burden index, which is composed of two metrics: TC and
the assessment of lymph nodes. The data consist of whole slide images (WSIs) of breast tissue stained
with Hematoxylin and Eosin (H&E) released in the 2019 SPIE Breast Challenge. The methodology
proposed is based on traditional computer vision methods (K-means, watershed segmentation,
Otsu’s binarisation, and morphological operations), implementing colour separation, segmentation,
and feature extraction. Correlation between morphological features and the residual TC after a
NAT treatment was examined. Linear regression and statistical methods were used and twenty-two
key morphological parameters from the nuclei, epithelial region, and the full image were extracted.
Subsequently, an automated TC assessment that was based on Machine Learning (ML) algorithms
was implemented and trained with only selected key parameters. The methodology was validated
with the score assigned by two pathologists through the intra-class correlation coefficient (ICC).
The selection of key morphological parameters improved the results reported over other ML
methodologies and it was very close to deep learning methodologies. These results are encouraging,
as a traditionally-trained ML algorithm can be useful when limited training data are available
preventing the use of deep learning approaches.
Keywords: neo-adjuvant treatment; digital pathology; tumour cellularity; machine learning
1. Introduction
Digital pathology has recently become a major player in Cancer research, disease detection,
classification, and even in outcome prognosis [1–4]. Perhaps the most common imaging technique
is Hematoxylin and Eosin (H&E), where H stains nuclei blue and E stains cytoplasm pink [5].
Additionally, other immunohistochemistry methods (IHC) that use antibodies to stain antigens
or proteins in the tissue are more specific and they can complement H&E [6]. For instance,
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the cluster of differentiation 31 (CD31), which is commonly found on endothelial cells, is used as
an indication of the growth of blood vessels in tumours, or angiogenesis [7–9]. CD34 is found on
hematopoietic cells, mesenchymal stem cells, and it is required in certain processes, like infiltration
of eosinophils into the colon [10], or the dendritic cell trafficking and pathology in pneumonitis [11],
Ki67 is normally associated with cell proliferation and it can be used as a prognostic factor for
gliomas [12], breast cancer [13], and colorectal adenocarcinomas [14]. Computer-assisted diagnosis
(CAD) [2] is based on the quantitative analysis to grade the level of the disease, but, recently, other
clinical-pathological relationships with the data have been explored [15,16]. For example, a better
understanding of mechanisms of the disease evolution process [1] and even prognosis information [3].
Breast Cancer is a common disease both in terms of incidence and deaths, with approximately
252,710 new cases and 40,610 deaths in 2017 in the United States alone [17]. In 2018, 30% of new
cases Cancer among females cases in the US were breast cancer, which placed it the second place in
mortality [18]. Numerous imaging analysis methods are employed in order to study these cancers [19].
Common treatments for breast cancer are surgery, radiation, chemotherapy, or targeted therapy.
Breast cancer neo-adjuvant treatment (NAT) is a therapy for advanced cases that provides useful
information for breast-conserving surgery [20]. NAT provides prognostic and survival information [21]
as well as a rate of local recurrence [22]. The efficacy of NAT is determined by means of the pathological
complete response (pCR) and this can be assessed by the Residual Cancer Burden (RCB) [23]. RCB is
supported by two metrics: residual Tumour Cellularity (TC) within the Tumour Bed (TB) and the
assessment of lymph nodes. RCB is scored in a continuous value, but it is further categorised in four
classes RCB-0 to RCB-III. Subsequently, TC, which is defined as the fraction of malignant cells within
the image patch, is a key parameter for RCB computation [24,25]. Currently, TC is manually assessed
by an eye-balling routine estimating the proportion of TB and this procedure is time-consuming and
requires an experienced pathologist.
Neo-adjuvant treatment (NAT) chemotherapy refers to a treatment that is administrated before
Cancer surgery [26–28]. The first successful results of NAT chemotherapy were demonstrated in the
1980s [29,30]. Some of the benefits of NAT are: tumour size reduction, better prognostics, and, even in
some cases, surgery can be avoided [31]. In addition, patients with large tumours could be eligible for
breast-conserving or a less tumour size surgery extraction.
TC assessment problem was first addressed by a hand engineering approach based on nuclei
segmentation and feature extraction. In the first step, nuclei segmentation needs to be implemented [1].
This is a challenging task and some common techniques are based on active contours [32], watersheds [33],
or graph cuts [34], which are either designed for nuclei [33] or lymphocytes segmentation. [32] Based on
the segmentation application, speed, accuracy, or automation level might be required [34]. In the present
study, automated segmentation is performed and, as it has been reported in some tissue classification
studies, accuracy nuclei segmentation does not guarantee better outcome assessment between benign
and malignant tissue [2]. When processing a high number of image files, speed constraint is preferable.
After segmentation, many features can be extracted, for instance, cell shape, size, and texture [33–35],
and also, features from regional and the global image can provide valuable information [36].
These parameters can be used for diagnostic purposes to classify tissue malignancy [36–39] and
also for grade disease level assignment. Ref. [33] For instance, a study conducted by Dong and
co-authors [40] categorised intraductal lesions in breast cancer by an adequate feature extraction and
machine learning (ML) classification.
ML algorithms are trained to learn from the parameters extracted [15]. Some supervised
algorithms are Support Vector Machines [41], Boosted Trees [42], and K-Nearest Neighbours [43].
Besides diagnosis, different new clinicopathological relationships with features have been discovered,
for example, [16] revealed the relation between stroma morphology and prognosis of breast cancer
patients and [44] studied quantification and distribution of tumour-infiltrating lymphocytes (TILs) as
prognostic and predictive biomarker.These type of digital pathology methodologies can also useful
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for TC assessment. A full hand-engineering method for this task was proposed by Peikari [45].
This methodology was based on the extraction of a vector with 125 parameters [45].
Separate to traditional ML techniques, another approach to estimate TC is by Deep Learning
(DL) techniques. In the last decade, there has been increased interest in DL methods. One of the
main architectures or models is based on the use of neural networks, and a particular case is a
Convolutional Neural Network (CNN) [46]. The main advantage of DL techniques is that they
do not require the extraction of features manually or by training, as the network learns a series
of parameters and weights by itself. However, to achieve this, the network requires a relatively
large number of training images with labels, and the number of training data can impact on the
performance. In many histopathology applications, labelled training data are still limited as compared
to other imaging applications, such as everyday images, like cats and dogs. With the spread use of
whole slide digital scanners [47], numerous histopathology images have become available for research
purposes. Some have been released to the research community in general in the form of challenges
(e.g., https://grand-challenge.org/challenges/) in order to encourage research groups globally to
work together, gather annotations, provide training, and testing data sets and benchmark algorithms.
The present work follows the 2019 SPIE-AAPM-NCI BreastPathQ: Cancer Cellularity Challenge with
the specific objective of “development of quantitative biomarkers for the determination of cancer
cellularity from whole slide images (WSI) of breast cancer hematoxylin and eosin (H&E) stained
pathological slides” ( https://breastpathq.grand-challenge.org/) and addresses the development of
quantitative biomarkers for the challenge.
CNNs have been used for different Histopathology tasks, like segmentation [48,49], detection of a
specific image properties [50] , and image grade classification [38,51]. Breast cancer tumour cellularity
has also been addressed by deep techniques. For instance, Ziang Pei [52] implemented a direct method
based on deep and transfer learning approach with the advantage of avoiding cell segmentation.
Akbar [20] presented a traditional hand-engineering approach and a deep neural network.
The methodology in this study is based on a hand-engineering approach similar to the one that
was described by [45] based on a 125 parameter vector size, but we selected 22 parameters after a
correlation analysis of extracted features with TC. Additionally, the methodology described here is
similar to Dong et al. parameters from nuclei; we also include parameters from the neighbourhood of
the nuclei and from the full image patch. The study by Fondon [36] also analysed regions around the
nuclei; however, our study includes morphology parameters from whole breast ducts region. Thus,
the main contributions of this paper in the methodology are the segmentation algorithm that is based
on the enhancement of the nuclei region, and an algorithm for breast ducts detection and the parameter
derivation and selection and its correlation to tumour cellularity. In the results, the correlation analysis
of the morphological parameters with cellularity revealed that stroma concentration has the strongest
correlation with TC, which is in agreement with the results that were presented by [16]. Finally,
the results were validated with the ICC and compared with similar studies [20,45] indicating an
increase in ICC. The methodology described only requires a reduced set of training parameters.
Therefore, the methodology described in this paper improves previous results and it may be useful in
cases when large training data sets, which are normally required for deep learning approaches, are
not available.
2. Materials and Methods
2.1. Materials
The data set used in this work consists of 2579 patches of tissue stained with H&E, which were
extracted from 64 different patients under Neo-adjuvant Treatment. The size of each patch is
512 × 512 pixels. As a reference, a breast tissue is formed of a connective tissue, named stroma,
as seen in pink. Lymphocytes can be seen as dark blue round objects and fat zones as white areas.
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It also contains ducts,which are responsible for carrying milk, and sometimes arteries, which can be
seen as regular clusters of darker blue nuclei grouped into the region (Figure 1).
(a) (b)
Figure 1. (a) Stroma region which shows several clusters, regions of fat as well as some lymphocytes.
(b) Graphical description of the elements that are analysed in this work. Within a stroma, the connective
tissue shown in pink region, ducts appear as clusters stained with haematoxylin and contain several
nuclei. Outside these ducts, regions of fat appear white and lymphocytes appear purple.
The residual cellularity of each patch was evaluated by 2 pathologists and this assessment was
considered to be the ground truth (GT) for this study. The data was released as part of the challenge
2019 and it was collected at the Sunnybrook Health Sciences Centre, Toronto. It comprises a set
of whole slide images (WSIs) that have been stained with H&E [45] from 64 patients with residual
invasive breast cancer on re-section specimens following NAT therapy. The specimens were handled
according to routine clinical protocols and WSIs were scanned at 20×magnification (0.5 µm/pixel).
The images were divided into a training and validation set of images. The cellularity value
distribution for the whole data-set is uneven, i.e., most of the patches correspond to cellularity zero
and fewer patches were available for higher cellularity. The training images were selected uniformly
distributed from cellularity zero to one in order to have an even amount of benign and malignant
nuclei. First, 212 images with selected cellularity values from 0 to 1 were processed and 4533 nuclei
cells from those selected images were extracted and its corresponding features computed and used
as a training set. The remaining 2367 patches were used for validation. Figure 2 shows the selected
patches with different levels of cellularity. A third set of test data of 1119 images was available for the
challenge contest. These three sets were used in this work.
2.2. Methodology
The proposed methodology consists of a sequence of traditional image processing routines,
computer vision, and machine learning algorithms that automatically process the full validation set.
A large amount of morphological parameters can be extracted and stored orderly in an output table
file. A master control routine is responsible for selecting one by one the corresponding image patch
to be processed. There are two operational modes. A manualmode useful to train machine learning
algorithms. In this mode, nuclei from the selected image with a known classification assignment are fed
to the algorithm and output features are saved in an output data file. Subsequently, an automated mode
processes the full validation set and gives a TC estimation. This mode is able to process thousands of
patch images. Figure 3 presents this process in a diagram.
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Figure 2. Graphical display of three selected morphological parameters against the cellularity: Global
stroma filtered region (o), minor axis (4) and Value concentration in region (x). Cellularity was
manually ranked by a pathologist and the parameters automatically extracted. The plots represent
average parameter value normalised with maximum value to be compared in the same graph.
The graph indicates an inverse relationship between respective parameter and cellularity. Thumbnails
show images with cellularity values from zero to one and magnified versions of cases with values 0,
0.4, 0.7, and 1, where the prevalence of cancerous cells can be clearly observed.
The methodology was implemented in Matlab R© (The MathworksTM, Natick, MA, USA) 2019b
version, with functions from the digital image processing, statistical, and machine learning toolboxes.
Additionally, QuPath [53], an open source software for digital pathology image analysis, was used
to validate the segmentation results obtained by the methodology. Three regions of interest were
selected from each image patch, and more than 150 morphological parameters were extracted at inner
segmented cell region, neighbourhood around segmented cell, and the full image patch.
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Figure 3. Graphical illustration of the pipeline of the methodology. Under two operational modes
images are processed to extract features at nuclei, regional, cluster, and global image regions either to
classify and assign Cellularity or to extract same features in order to an archive output.
2.3. Segmentation of Nuclei
At the nuclei region, cells from the image patch are segmented by colour separation and
binarisation. The image is converted to HSV colour space and, by K-means clustering [54], three main
colour images are extracted, say Ip for pink, Ib for blue, and Iba for the remaining background
component image. A special procedure enhances Ib and weakens background region is calculated as:
In = K1(Io. ∗ Im) + K2 Io+ γ(Im, 0.1) (1)
where Io is the RGB image converted to gray levels and Im is gray image after a median filter of
size 3× 3 was applied. γ is the gamma correction Im of parameter 0.1 represented as γ(Im, 0.1).
This value was selected as low to start from a lighter background. K1 and K2 are constants that control
enhancement of nuclei and weaken background intensity, respectively, and they were experimentally
adjusted. First, both of the constants were fixed to 0.5 and, as K1 is increased and K2 is reduced,
the nuclei region is enhanced. The enhanced image In is binarised by Otsu’s algorithm [55] combined
with watershed [56] separation of touching nuclei. This segmentation procedure is seen in Figure 4
for three TC cases. A validation analysis of this procedure was done by means of Jaccard Index [57],
as shown in (e). The reference images were obtained by a manual segmentation while using the
QuPath platform. The results indicate an average Jaccard index of 0.73 after comparing cases of low,
medium, and high TC. Although this result might be improved, Peikari and co-authors [45] suggest
that cell segmentation accuracy does not have a significant effect in TC assessment.
2.4. Extraction of Morphological Parameters
Using the binary image, a set of morphological parameters has been obtained: area, perimeter,
roundness, eccentricity, centroid X, centroid Y, major axis, minor axis, and orientation angle.
Additionally, a sub region inside the segmented cell body was determined in order to compute
the texture and mean HSV values of the nuclei cell body.
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(a) (b) (c) (d) (e)
Figure 4. Enhancement of nuclei area. First row corresponds to a Tumour Cellularity (TC) value of
zero, second row is an example of TC= 0.5 and third row is TC= 1. Images in column (a) are the
original image, (b) gray level images, (c) enhanced images, notice that the nuclei region is darker whilst
background becomes lighter, (d) Binary image obtained with an adaptive threshold value estimated
directly from strongest correlated parameter, and (e) validation of nuclei segmentation by Jaccard index.
Reference image was manually segmented by using QuPath Platform.
The parameters were extracted from different window sizes surrounding the segmented cell:
30× 30, 60× 60, 90× 90, and 120× 120 pixels. The statistical analysis indicated that the best correlation
was obtained from the smallest window size. The parameters estimated are the four bins histogram
from HSV image and also the regional concentration R of Ip, Iba, and Ib from its binary image,
determined by the ratio of total white pixels TW by total pixels TP inside window neighbourhood
region, R = TW/TP. Figure 5 shows a sample patch image, with its corresponding pink, blue, binary,
and concentration image components. Brown areas indicate low concentration and white and yellow
areas are high concentration. Breast normal tissue images present ducts and sometimes arteries,
which are clearly seen as regular clusters of darker blue nuclei grouped into the region, see Figure 6.
These are detected based on set theory: let U be the full image, D be the cluster or duct, D⊆U 6= ∅.
Subsequently, D regions are obtained by subtracting background image Iba from original image
U. The following morphological parameters can be extracted from these regions: total cluster area,
roundness, number of cells inside cluster, and distance from cells centroid to cluster centroid.
Concentration parameters from the complete full image patch were computed using original
RGB image and transformed to HSV. Additionally, a pink colour filter was implemented by means
of the Matlab R© colour thresholder, which extracts stroma region from the image and computes its
mean value. A summary of the full set of features extracted is presented in Table 1; notice that regional
parameters are computed at the different window sizes.
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(a) (b) (c)
(d) (e)
(f) (g)
Figure 5. Regional analysis of the data. (a) Original image. (b) Ip, stroma region image obtained
from colour separation. (c) Binarised Ip image. (d) Ib nuclei image obtained from colour separation.
(e) Binarised Ib image. (f) Regional image concentration of Ip in which brown colour indicates
the lowest and white is the highest region concentration. (g) Regional density concentration of Ib.
This example was processed at 30× 30 pixels window.
(a) (b)
(c) (d)
Figure 6. (a) The original patch with clear breast ducts. (b) Clusters detected by the methodology, every
duct or cluster is in yellow and cells inside are in red. Background is labelled in white. (c,d) Magnified
regions of (a,b).
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Table 1. Summary of extracted features. Features at regional level are computed at four different
window sizes. Features from the full image represent average values.
Nuclei Area Eccentricity Roundness Centroid x, y
Perimeter Orientation Major Axis Minor Axis
Mean Texture
Contrast 1
Mean Texture
Contrast 2
Mean Texture
Homogenity 1
Mean Texture
Homogenity 2
Mean H value
inside nuclei
Mean V value
inside nuclei
Mean S value
inside nuclei
Regional
Concentrations Stroma Ip Background Iba Nuclei Ib
Epithelial tissue
from Ib
Mean H
in window
Mean S
in window 2
Mean V
in window
Mean intensity
Histogram H 1
Mean intensity
Histogram H 2
Mean intensity
Histogram H 3
Mean intensity
Histogram H 4
Mean intensity
Histogram S 1
Mean intensity
Histogram S 2
Mean intensity
Histogram S 3
Mean intensity
Histogram S 4
Mean intensity
Histogram V 1
Mean intensity
Histogram V 2
Mean intensity
Histogram V 3
Mean intensity
Histogram V 4
Clusters
(ducts)
Cluster
area
Cluster
roundness
Cells inside
cluster
Distance to
centroid
Global Image
Concentrations Stroma Ip Background Iba Nuclei Ib
H value V Value S Value
2.5. Correlation Analysis of Morphological Parameters to TC
The full training set was processed to determine all of the morphological parameters at the three
region of interest and those corresponding to Cellularity values equal to (0, 0.1, 0.2, ..., 1.0) were selected,
and their mean, standard deviation, maximum, and minimum values were computed. Subsequently, a
linear regression and lasso analysis were determined from both analyses. Parameters of coefficient
above 0.80 from linear regression and in concordance with lasso selected parameters after redundant
removal yield 22 parameters that have the strongest correlation with TC. The plot in in Figure 2
illustrates three parameters with the strongest correlation with TC.
First, the morphological parameters related to segmented nuclei are: eccentricity, roundness,
major axis, minor axis, and perimeter. Subsequently, parameters computed at neighbourhood region
are: nuclei density concentration, Hue, Value, and Saturation histograms of the regional HSV colour
map image. Finally, parameters that are computed from the full image are: HSV average values from
HSV components, nuclei concentration, basement concentration, and stroma average concentration
determined at output of the pink colour filter. Some of these parameters are graphically displayed
in Figure 7.
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(a) (b)
Figure 7. Morphological relationship between the four strongest correlated parameters. (a) Global
value from HSV component and Stroma average Concentration. (b) Background Image Concentration
and Stroma Filtered Concentration. In both cases, the benign and malignant cells are highlighted with
different colours, which indicate a clear separation.
2.6. Training of Machine Learning Algorithms
Machine learning algorithms were trained with the parameter vector of size 22 determined by
the statistical correlation analysis. From the training set, 4533 segmented cells were processed and its
corresponding extracted parameters were used to generate a prediction function that classifies nuclei
cells between malignant and normal cells. Three algorithms were tested: Support Vector Machines,
Nearest K-Network, and AdaBoost. The accuracy of training process for every selected method
with the training data showed values up to 0.99 due to a high correlation selected features used for
training. TPR achieved are 0.97 for SVM, 0.95 for AdaBoost, and 0.97 for KNN (Figure 8). Support
Vector Machines (SVM) is a training algorithm for optimal margin classifier [41], and it is based on
a determination of a decision function of pattern vectors x of dimension n classifying in either A or
B, in our case benign or malignant cells. The input is a set of p examples of xi, i.e., the 22 strongest
correlated features extracted. K-Nearest Neighbour method [42] was also selected, because it is one
of the most well known algorithms within clustering and data classification, in our case between
benign and malignant classes. AdaBoost [43] is a decision tree type learning algorithm that starts from
observations of a certain item that is represented by branches and goes to conclusions about item target
value or leaves. It has a best performance on binary classification problems.
(a) (b) (c)
Figure 8. (a) Receiver operating characteristic (ROC) curves obtained during training phase for the
three selected algorithms. (a) Support Vector Machines (SVM), (b) AdaBoost , and (c) K-Nearest
Neighbour (KNN). The higher accuracy value achieved is obtained only with the training set that is
highly correlated with Tumour Cellularity (TC).
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2.7. Assessment of Tumour Cellularity
The methodology to estimate TC is illustrated in Figure 9, with three representative images
with increasing TC from top to bottom in each row. In Figure 9a the nuclei are segmented and their
corresponding parameters are extracted. Subsequently, the prediction function classifies every cell
in either benign (green) or malignant (red), as illustrated in Figure 9b. Next, an estimation of full
cell cytoplasm is done by morphological dilation drawn as the white circles around malignant cells
(Figure 9c). The full cellularity that is detected region is shown in Figure 9d. TC is computed as the
ratio of the area that is covered by cellularity (white in the figure) over the total area (white and black
in figure).
(a) (b) (c) (d)
Figure 9. Visual description of the method. Three TC cases are presented in each row: 0, 0.5 and 1.
(a) The original image, the image is segmented and key parameters are computed, then a classification
predictor estimates either malignant or benign cells, shown in red and green, respectively in (b).
A dilation of segmented malignant nuclei estimates full cytoplasm of every detected malignant cell (c)
and TB region is shown in white in (d). The cellularity metrics calculated by the proposed methodology
are: TC = 0.0113, TC = 0.5181 and TC = 0.9936.
3. Results
An automated estimation of TC was computed from two test data sets. Three prediction functions
that were trained by machine learning algorithms were determined to be used with the automated
processing software of breast cancer images that classifies cells and computes TC. The method was
tested with a training set of 2579 images that were already classified by a pathologist with a TC value.
Additionally, it was tested with the 1119 images for submission of SPIE Breast Challenge, with an
unknown TC value. Figure 10 shows the statistical behaviour of the method’s result for the training
set as boxplots.
Dispersion plot indicates the method for approximating to the pathologist classification
assignment. The results have a better approximation at higher cellularity values (TC > 0.70) and
performs well with KNN algorithm. Additionally, around the middle region (0.4 < TC < 0.6) has
a good approximation with AdaBoost. At low cellularity values (TC < 0.3), three methods present
deviation, with its higher at cellularity zero, which correspond to images with only benign nuclei cells.
According to Minimum Square Error (MSE), SVM performs better overall in the cellularity region.
J. Imaging 2020, 6, 101 12 of 17
This result can be validated by a visual inspection of boxplots of Figure 10 in the three cases there is a
positive correlation between the actual cellularity (horizontal) and the estimated cellularity (vertical).
However, SVM shows less dispersion, especially in the lower values of cellularity as compared with
the other two techniques.
(a) (b)
Figure 10. Results of implementation on Training Data. Boxplots for the Cancer Cellularity Reference
Value against: (a) SVM estimation, (b) KNN estimation and (c) BT Estimation. It should be noted that
large boxplots correspond to large variations of the estimations and as such, SVM shows the lowest
variability
In order to analyse the limitations of the algorithm, the TC assessment outcomes with the highest
errors were analysed. Figure 11 presents three cases where the TC was incorrectly calculated. All three
cases in the figure are of benignant tissue with no cellularity; this means that most of the segmented
cells should be marked as benignant (green), but several of them are shown in red (b–d), which
corresponds to false-positive cases. The expanded area around the cell (e) yields a high TC value
instead of the correct value which should have been zero. We assume that this problem is because of
the limited amount of cells used to train the algorithm. This problem also explains some of the outliers
on the boxplots presented in Figure 10, which are mainly observed at low cellularity. Additionally, this
suggests that other classification algorithms should be evaluated.
(a) (b) (c) (d) (e)
Figure 11. Three cases where the TC was incorrectly calculated. Each row corresponds to a patch
with incorrect TC. Column (a) illustrates the original image, and columns (b–e) show the step by step
process to assess cellularity. (b) Corresponds to the segmented image and classified into benign (green)
and malignant (red). Columns (c,d) show expanded region of malignant cells. Column (e) corresponds
to cancer cell region in white, used to compute TC. Three worst cases correspond to a TC of zero;
this means there would not be any malignant cell and TC image must be completely black. Several
cells were miss classified which yields to a TC wrong assessment. Estimated TC values are: 0.75, 0.81,
and 0.75, instead of zero.
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Statistical analysis of the training set revealed 22 key parameters that have a strong correlation to
TC. The Stroma concentration (r = −0.9786), global Value of HSV component (r = −0.9728), regional
histogram bins (r = −0.9659), and minor axis (r = 0.8939) from nuclei morphology were the strongest
parameters, as shown in Figure 2.
This result revealed that the stroma region has a significant relation to TC, which is in agreement
with the results of the hand engineering method by [45] that was trained by a 125-dimensional feature
vector reported a 0.75 ICC (first column of Table 2). Lower and upper-bounds are shown in square
brackets. Our methodology is also a hand engineering, but trained with only 22 key morphological
parameters (second column of Table 2), indicates a 0.78 ICC. This result outperformed those that were
obtained by the method of Peikari. The results based on Deep Learning techniques like a combined
hand engineering Deep Neural Network reported by Akbar [20] is slightly above the proposed
methodology (third column of Table 2). Finally, the methodology proposed was used to process the test
set and the results were submitted to the challenge contest. The prediction probability result obtained
from contest was Pk = 0.76.
Table 2. Comparison of the Intra-class Correlation Coefficients (ICC) of the proposed methodology
against a Hand Engineering Methodology (Peikari [45]) and a combined deep learning and hand
engineering methodology (Akbar [20]). Lower and upper bounds are shown in square brackets. Notice
the closeness of the results of the proposed methodology against the Deep Learning approach.
Hand Engineering Key Parameters Combined Deep Network
(Peikari) (Our methodology) (Akbar)
ICC 0.75 0.78 0.79
[L,U] [0.71, 0.79] [0.75, 0.80] [0.76, 0.81]
4. Discussion
A computer methodology that automatically processes H&E histopathology digital images based
in the extraction of main morphological parameters at a cell, regional, and global level is presented in
this paper. The methodology processed a training set of breast cancer images under NAT treatment and
the results indicate 22 key morphological parameters are strongly correlated with cellularity. Interesting
results were revealed from the correlation analysis of the morphological parameters. The strongest
related parameter was stroma density, in agreement with Beck et al. [16], which is, the histology of
stroma correlates with prognostic in breast cancer. Three different machine learning algorithms for
cell classification were evaluated and compared in order to determine tumour regions. The best
result was obtained with Support Vector Machines (SVM) algorithm. The relevance of this paper
is a selection of a key parameters to train the algorithms, which results in a better performance of
similar techniques; however, the reported deep learning algorithms outperform this result, which is a
motivation to explore these techniques in the future.
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Abbreviations
The following abbreviations are used in this manuscript:
TC Tumour Cellularity
NAT Neo-Adjuvant treatment
WSIs Whole slide images
H&E Hematoxylin and Eosin
ICC Intraclass correlation coefficient
ML Machine Learning
IHC Immunohistochemistry
CAD Computer-assisted diagnosis
RCB Residual Cancer Burden
pCR Pathological complete response
TB Tumour Bed
GT Ground Truth
HSV Hue, Saturation, Value
RGB Red, Green, Blue
SVM Support Vector Machines
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